Nathan I - Search Results

1

The anti-leukaemic activity of novel synthetic naphthoquinones against acute myeloid leukaemia: induction of cell death via the triggering of multiple signalling pathways.

Hallak M, Win T, Shpilberg O, Bittner S, Granot Y, Levy I, Nathan I. Hallak M, et al. Among authors: nathan i. Br J Haematol. 2009 Nov;147(4):459-70. doi: 10.1111/j.1365-2141.2009.07867.x. Epub 2009 Aug 31. Br J Haematol. 2009. PMID: 19747367 Free article.

2

Induction of death of leukemia cells by TW-74, a novel derivative of chloro-naphthoquinone.

Hallak M, Thakur BK, Winn T, Shpilberg O, Bittner S, Granot Y, Levy I, Nathan I. Hallak M, et al. Among authors: nathan i. Anticancer Res. 2013 Jan;33(1):183-90. Anticancer Res. 2013. PMID: 23267144

3

A molecular mechanism for mimosine-induced apoptosis involving oxidative stress and mitochondrial activation.

Hallak M, Vazana L, Shpilberg O, Levy I, Mazar J, Nathan I. Hallak M, et al. Among authors: nathan i. Apoptosis. 2008 Jan;13(1):147-55. doi: 10.1007/s10495-007-0156-7. Apoptosis. 2008. PMID: 18058236

4

Novel pyrrolidine-aminophenyl-1,4-naphthoquinones: structure-related mechanisms of leukemia cell death.

Hallak M, Danilenko M, Win T, Bittner S, Granot Y, Shpilberg O, Levi I, Nathan I. Hallak M, et al. Among authors: nathan i. Mol Cell Biochem. 2023 Feb;478(2):393-406. doi: 10.1007/s11010-022-04514-0. Epub 2022 Jul 14. Mol Cell Biochem. 2023. PMID: 35836027

5

Multifactorial activities of nonsteroidal antiestrogens against leukemia.

Hayon T, Atlas L, Levy E, Dvilansky A, Shpilberg O, Nathan I. Hayon T, et al. Among authors: nathan i. Cancer Detect Prev. 2003;27(5):389-96. doi: 10.1016/s0361-090x(03)00102-8. Cancer Detect Prev. 2003. PMID: 14585326

6

Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma.

Vazana-Barad L, Granot G, Mor-Tzuntz R, Levi I, Dreyling M, Nathan I, Shpilberg O. Vazana-Barad L, et al. Among authors: nathan i. Leuk Lymphoma. 2013 Apr;54(4):851-9. doi: 10.3109/10428194.2012.734614. Epub 2013 Jan 2. Leuk Lymphoma. 2013. PMID: 23020673

7

Clomiphene as a novel modality for the treatment of acute myeloid leukemia: A pilot phase II study.

Yom-Tov G, Nathan I, Shpilberg O, Polliack A, Levi I. Yom-Tov G, et al. Among authors: nathan i. Leuk Res. 2012 Jan;36(1):42-5. doi: 10.1016/j.leukres.2011.08.015. Epub 2011 Oct 4. Leuk Res. 2012. PMID: 21974857 Clinical Trial.

8

Appraisal of the MTT-based assay as a useful tool for predicting drug chemosensitivity in leukemia.

Hayon T, Dvilansky A, Shpilberg O, Nathan I. Hayon T, et al. Among authors: nathan i. Leuk Lymphoma. 2003 Nov;44(11):1957-62. doi: 10.1080/1042819031000116607. Leuk Lymphoma. 2003. PMID: 14738150 Review.

9

Involvement of proteases in the action of IFN-gamma on WISH cells.

Aharon M, Dvilansky A, Shpilberg O, Nathan I. Aharon M, et al. Among authors: nathan i. J Interferon Cytokine Res. 2002 Aug;22(8):847-52. doi: 10.1089/107999002760274854. J Interferon Cytokine Res. 2002. PMID: 12396723

10

Cardiolipin plays a role in KCN-induced necrosis.

Tsesin N, Khalfin B, Nathan I, Parola AH. Tsesin N, et al. Among authors: nathan i. Chem Phys Lipids. 2014 Oct;183:159-68. doi: 10.1016/j.chemphyslip.2014.06.007. Epub 2014 Jul 1. Chem Phys Lipids. 2014. PMID: 24995676

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters